MEDIROM Healthcare Technologies
MRM
4 hedge funds and large institutions have $116K invested in MEDIROM Healthcare Technologies in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
47% more capital invested
Capital invested by funds: $79K → $116K (+$37K)
33% more funds holding
Funds holding: 3 → 4 (+1)
0.05% more ownership
Funds ownership: 0.27% → 0.32% (+0.05%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$12.6K |
| 2 |
JP Morgan Chase
New York
|
+$10.9K |
| 3 |
Citigroup
New York
|
+$2.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.24K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $88K | -$6.24K | -920 | -7% |
|
|
2
Morgan Stanley
New York
| $14K | +$12.6K | +1,857 | +4,319% |
|
|
3
JP Morgan Chase
New York
| $12K | +$10.9K | +1,600 | New |
|
|
4
Citigroup
New York
| $2K | +$2.02K | +297 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$1K | -189 | Closed |
|
MRM Hedge Fund Activity: Q1 2022 in Review
4 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q1 2022, worth a combined $116K — up 47% from $79K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MRM positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $12.6K. The largest seller was UBS Group, cutting an estimated $6.24K.
- 4 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q1 2022, up from 3 in Q4 2021.
- Funds reported $116K of MEDIROM Healthcare Technologies stock for Q1 2022, up 47% quarter-over-quarter.
- 2 funds opened new MEDIROM Healthcare Technologies positions in Q1 2022 and 1 closed out, a net change of +1 holder.
- The largest MEDIROM Healthcare Technologies buyer in Q1 2022 was Morgan Stanley, an estimated $12.6K added.
- The largest MEDIROM Healthcare Technologies seller in Q1 2022 was UBS Group, an estimated $6.24K sold.
Based on aggregated 13F filings for Q1 2022.